From GlobeNewswire: 2025-05-07 08:30:00

The Preclinical Imaging Market was valued at USD 4.18 billion in 2023, expected to reach USD 6.31 billion by 2032 with a CAGR of 4.69%. Factors driving growth include R&D investments, advancements in imaging tech, and demand for non-invasive techniques in drug discovery. The U.S. leads North America’s market at USD 1.05 billion in 2023, projected to reach USD 1.45 billion by 2032 with a CAGR of 3.72%.

Key companies in the Preclinical Imaging Market include PerkinElmer, Siemens, GE, Mediso, Molecubes, TriFoil, FUJIFILM, MILabs, Bruker, and Agilent Technologies. The market report covers a range of products and services, with a focus on optical imaging dominating the market in 2023. Multimodal imaging is expected to see rapid growth, offering a combination of imaging modalities for better disease process understanding.

The Research & Development segment dominates the market, with a focus on drug discovery, disease research, and therapy efficacy assessment. Pharma and biotech companies lead the market due to heavy usage of imaging tech in drug development procedures. North America leads the market, with Asia Pacific expected to see the fastest growth. Advanced imaging systems are crucial for precise data in drug discovery and therapy monitoring. The preclinical imaging market is driven by drug discovery and translational research, with Asia Pacific expected to be the fastest-growing region due to increased biotech and pharma sectors. Healthcare spending and government support for R&D are accelerating the adoption of advanced imaging modalities in the region.

For in-depth analysis, the Preclinical Imaging Market Analysis & Outlook Report 2024-2032 is available for purchase. The report covers market dynamics, statistical insights, competitive landscape, regional analysis, and company profiles. Related reports on molecular imaging, clinical trial imaging, digital pathology, and small animal imaging are also available.

SNS Insider is a leading market research and consulting agency providing clients with accurate market data and consumer insights. Utilizing surveys, video talks, and focus groups globally, the company aims to empower clients to make confident decisions in evolving market conditions.



Read more at GlobeNewswire: Preclinical Imaging Market Projected to Reach USD 6.31